Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Can prior cigarette smoking leave persistent endothelial dysfunction and atherosclerotic risk after quitting?

Former cigarette smoking can leave long-lived excess atherosclerotic risk after cessation, especially after heavier exposure, and persistent endothelial dysfunction is a plausible contributing mechanism.

PlausibleSeptember 14, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Prior cigarette smoking can cause persistent endothelial dysfunction and atherosclerotic risk after cessation through oxidative injury, reduced nitric oxide bioavailability, and lasting vascular remodeling.

laying out figure…
1 of 8 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that smoking-related vascular harm may not fully normalize after quitting, with residual risk lasting longer in people with greater cumulative exposure. The mechanism framing links this to oxidative injury, reduced nitric oxide bioavailability, and lasting vascular remodeling, which can help explain why former smokers may retain more plaque burden and endothelial impairment than never-smokers.

Verified conclusion

Former cigarette smoking remains clinically relevant because vascular risk falls substantially after quitting but may not return promptly to that of never-smokers, especially after higher cumulative exposure.

Clinical and imaging evidence

  • In a cohort of 5.3 million people, former smokers with ≥8 pack-years retained statistically detectable excess cardiovascular risk versus never-smokers until more than 25 years after cessation. Those with lower cumulative exposure had no significant residual excess risk.
  • Pooled cohort data similarly show major risk reduction compared with continued smoking, while heavier former smokers retain excess risk for years.
  • Multimodality imaging meta-analysis found that former smokers have an intermediate coronary plaque burden—lower than current smokers but greater than never-smokers—supporting durable atherosclerotic consequences of prior exposure.

Endothelial and mechanistic interpretation

  • Smoking impairs nitric-oxide–dependent endothelial function in an exposure-related fashion. Cessation improves flow-mediated dilation over one year, and longer abstinence is associated with better resistance-artery endothelial measures. This supports recovery, but potentially incomplete or heterogeneous recovery after substantial exposure.
  • Tobacco smoke increases reactive oxygen species, which scavenge nitric oxide and promote endothelial nitric-oxide synthase (eNOS) uncoupling, including through reduced tetrahydrobiopterin. The resulting reduction in nitric oxide bioavailability impairs endothelium-dependent vasodilation.
  • Oxidative and nitric-oxide abnormalities generally improve after cessation. Their role as persistent mediators in former smokers is therefore biologically credible but not directly established. Likewise, durable vascular remodeling is consistent with persistent plaque burden and risk, but has not been directly demonstrated as the causal bridge to later endothelial dysfunction or events.

Bottom line

  • Prior heavy smoking can leave long-lived excess atherosclerotic risk despite cessation; persistent endothelial dysfunction and lasting oxidative/NO-related or structural vascular effects are plausible explanations, while quitting still produces substantial vascular recovery.

References

  1. Cigarette smoking is associated with dose-related and ... — pubmed.ncbi.nlm.nih.gov ↗
  2. Effects of Smoking and Smoking Cessation on Endothelial Function: 1-Year Outcomes From a Randomized Clinical Trial — jacc.org ↗
  3. Cigarette Smoking Is Related to Endothelial Dysfunction of ... — frontiersin.org ↗
  4. The impact of tetrahydrobiopterin administration on ... — nature.com ↗
  5. Tobacco smoking and vascular biology and function: evidence ... — link.springer.com ↗
  6. Association of Smoking Cessation With Subsequent Risk of ... — natap.org ↗
  7. Smoking Cessation and Incident Cardiovascular Disease — jamanetwork.com ↗
  8. Cigarette smoking, coronary plaque burden and phenotype: a multimodality meta-analysis and implications for coronary artery calcium scoring in prevention — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→